B. Vetter

发表

Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.

N. Blau, C. Bührer, J. Hennermann, 2005, Molecular genetics and metabolism.

Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of cushing's disease with low doses

R. A. Zeeuw, B. Vetter, R. Benecke, 2004, European Journal of Clinical Pharmacology.

Beta‐thalassaemia in the immigrant and non‐immigrant German populations

A. Kulozik, E. Kohne, B. Vetter, 1997, British journal of haematology.

Oral isobutyramide reduces transfusion requirements in some patients with homozygous β-thalassemia

G. Henze, A. Kage, A. Kulozik, 2000 .

Long-term treatment with tetrahydrobiopterin in phenylketonuria: treatment strategies and prediction of long-term responders.

J. Hennermann, E. Mönch, B. Vetter, 2012, Molecular genetics and metabolism.

A negative personal and family history for venous thrombotic events is not sufficient to exclude thrombophilia in patients with cerebral venous thrombosis

J. Valdueza, F. Masuhr, M. Weih, 2004, European journal of neurology.

Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency

G. Gaedicke, S. Ziemer, M. Uttenreuther-Fischer, 1997, European Journal of Pediatrics.

Features and outcome of galactokinase deficiency in children diagnosed by newborn screening

J. Hennermann, Julia B. Hennermann, Peter Schadewaldt, 2011, Journal of Inherited Metabolic Disease.

Oral isobutyramide reduces transfusion requirements in some patients with homozygousb-thalassemia

G. Henze, A. Kage, A. Kulozik, 2000 .

An Unexpectedly High Frequency of Hypergalactosemia in an Immigrant Bosnian Population Revealed by Newborn Screening

A. Söling, A. Kulozik, L. Neumann, 2002, Pediatric Research.

[Remifentanil and alfentanil: Sympathetic-adrenergic effect in the first postoperative phase in patients at cardiovascular risk].

D. Olthoff, V. Thieme, B. Vetter, 1999, Der Anaesthesist.

Chronic Haemolytic Anaemia and Glucose-6-Phosphate Dehydrogenase Deficiency

A. Kulozik, P. Hundsdoerfer, B. Vetter, 2002, Acta Haematologica.

[Comparison of various methods of anesthesia by plasma catecholamine determination].

D. Olthoff, B. Vetter, S. Lange, 1995, Anaesthesiologie und Reanimation.

Dominant beta-thalassaemia: a highly unstable haemoglobin is caused by a novel 6 bp deletion of the beta-globin gene.

G. Gaedicke, G. Neu-Yilik, A. Kulozik, 2000, British journal of haematology.

Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia

Matthias W. Hentze, M. Hentze, G. Neu-Yilik, 2001, Nature Genetics.

[Modulation of the stress response in children in the preoperative preparation].

D. Olthoff, L. Wild, B. Vetter, 1997, Der Anaesthesist.

Chronic kidney disease in adolescent and adult patients with phenylketonuria

U. Querfeld, J. Hennermann, U. Plöckinger, 2013, Journal of Inherited Metabolic Disease.

Homozygous and double heterozygous Factor V Leiden and Factor II G20210A genotypes predispose infants to thromboembolism but are not associated with an increase of foetal loss

R. Rossi, S. Ziemer, A. Kulozik, 2003, Thrombosis and Haemostasis.

Phenylketonuria and hyperphenylalaninemia in eastern Germany: A characteristic molecular profile and 15 novel mutations

A. Kulozik, C. Wolf, J. Hennermann, 2000, Human mutation.

[Beta thalassemia in Germany: molecular genetics and clinical phenotype in immigrant and in the native population].

A. Kulozik, E. Kohne, B. Vetter, 1997, Klinische Padiatrie.

HB S-HB Monroe; a sickle cell-beta-thalassemia syndrome.

A. Kulozik, G. Serjeant, B. Serjeant, 1998, Hemoglobin.

Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis

S. Ziemer, A. Kulozik, J. Valdueza, 1998, Journal of Neurology.